Dr. Adam Rush, MD

NPI: 1528095643
Total Payments
$3,241
2024 Payments
$436.19
Companies
10
Transactions
122
Medicare Patients
178
Medicare Billing
$28,485

Payment Breakdown by Category

Food & Beverage$2,599 (80.2%)
Travel$641.84 (19.8%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,599 119 80.2%
Travel and Lodging $641.84 3 19.8%

Top Paying Companies

Company Total Records Latest Year
Medtronic, Inc. $1,670 26 $0 (2023)
ABBVIE INC. $625.91 53 $0 (2024)
Medtronic USA, Inc. $394.83 10 $0 (2020)
Supernus Pharmaceuticals, Inc. $195.55 12 $0 (2024)
Allergan, Inc. $118.31 8 $0 (2022)
Ipsen Biopharmaceuticals, Inc $100.58 6 $0 (2022)
Collegium Pharmaceutical, Inc. $73.52 4 $0 (2024)
DJO, LLC $23.83 1 $0 (2017)
Lilly USA, LLC $20.21 1 $0 (2024)
Fidia Pharma USA Inc. $19.04 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $436.19 34 ABBVIE INC. ($234.12)
2023 $1,871 52 Medtronic, Inc. ($1,498)
2022 $97.00 6 ABBVIE INC. ($32.41)
2021 $275.84 10 Medtronic, Inc. ($171.48)
2020 $53.84 4 Ipsen Biopharmaceuticals, Inc ($28.11)
2019 $265.26 6 Medtronic USA, Inc. ($237.33)
2018 $117.10 4 Medtronic USA, Inc. ($85.54)
2017 $125.55 6 Medtronic USA, Inc. ($60.91)

All Payment Transactions

122 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $13.95 General
Category: VILOXAZINE HYDROCHLORIDE
12/02/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $7.88 General
Category: BOTOX THERAPEUTIC
11/19/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $4.38 General
Category: NEUROSCIENCE
11/02/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $23.19 General
Category: VILOXAZINE HYDROCHLORIDE
10/28/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $8.14 General
Category: BOTOX THERAPEUTIC
10/09/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $24.15 General
Category: Opioid Analgesic
10/02/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $5.21 General
Category: NEUROSCIENCE
09/04/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $21.39 General
Category: NEUROSCIENCE
08/29/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $5.43 General
Category: NEUROSCIENCE
08/21/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $16.79 General
Category: BOTOX THERAPEUTIC
08/15/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $5.36 General
Category: NEUROSCIENCE
08/14/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $17.15 General
Category: Opioid Analgesic
08/09/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $14.37 General
Category: VILOXAZINE HYDROCHLORIDE
08/01/2024 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $20.21 General
Category: Neuroscience
07/24/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $7.18 General
Category: BOTOX THERAPEUTIC
07/10/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $16.55 General
Category: Opioid Analgesic
07/10/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $6.46 General
Category: NEUROSCIENCE
07/02/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $15.99 General
Category: VILOXAZINE HYDROCHLORIDE
07/02/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $7.13 General
Category: NEUROSCIENCE
05/30/2024 ABBVIE INC. UBRELVY (Drug), BOTOX Food and Beverage In-kind items and services $24.08 General
Category: NEUROSCIENCE
05/28/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $7.27 General
Category: NEUROSCIENCE
05/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $13.51 General
Category: VILOXAZINE HYDROCHLORIDE
04/30/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $8.17 General
Category: NEUROSCIENCE
04/23/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $19.01 General
Category: NEUROSCIENCE
04/17/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $15.67 General
Category: Opioid Analgesic

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 57 98 $20,228 $8,424
2022 3 64 124 $24,818 $9,975
2021 2 43 95 $16,507 $7,280
2020 1 14 38 $8,062 $2,806
Total Patients
178
Total Services
355
Medicare Billing
$28,485
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 26 49 $10,606 $4,384 41.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 13 18 $5,140 $2,228 43.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 18 31 $4,483 $1,813 40.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 27 50 $10,608 $4,152 39.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 23 49 $7,085 $3,004 42.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 14 25 $7,125 $2,819 39.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 19 41 $8,699 $3,647 41.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 24 54 $7,808 $3,632 46.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 14 38 $8,062 $2,806 34.8%

About Dr. Adam Rush, MD

Dr. Adam Rush, MD is a Physical Medicine & Rehabilitation healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528095643.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Rush, MD has received a total of $3,241 in payments from pharmaceutical and medical device companies, with $436.19 received in 2024. These payments were reported across 122 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,599).

As a Medicare-enrolled provider, Rush has provided services to 178 Medicare beneficiaries, totaling 355 services with total Medicare billing of $28,485. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Other Specialties Physical Medicine & Rehabilitation, Physical Medicine & Rehabilitation
  • Location Grand Rapids, MI
  • Active Since 06/26/2006
  • Last Updated 08/02/2019
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1528095643

Products in Payments

  • SYNCHROMEDII (Device) $1,498
  • SYNCHROMED (Device) $400.35
  • UBRELVY (Drug) $284.77
  • BOTOX (Biological) $215.30
  • QULIPTA (Drug) $209.07
  • Qelbree (Drug) $108.34
  • QELBREE (Drug) $87.21
  • ASCENDA (Device) $84.32
  • Belbuca (Drug) $73.52
  • SPECIFY (Device) $67.56
  • DYSPORT (Drug) $63.29
  • CMF OL1000 (Device) $23.83
  • Dysport 300 U-1 (Drug) $23.41
  • EMGALITY (Drug) $20.21
  • HYMOVIS (Device) $19.04
  • BOTOX THERAPEUTIC (Biological) $17.68
  • BOTOX - NEURO REHAB (Drug) $17.40
  • LIORESAL (Device) $14.08
  • Dysport (Drug) $13.88

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Grand Rapids